TOP TIERMARKET NEWSWIRE
News & sentiment

iShares US Pharmaceuticals ETF (IHE) — News & AI sentiment

iShares US Pharmaceuticals ETF (IHE) news roundup. 1 story in the past week, 3 over 30 days. Average 30-day sentiment is 54/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
1
avg sentiment 55/100
30d stories
3
avg sentiment 54/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

IHE news in the last 24 hours, 7 days, 30 days and 90 days

How much IHE coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowIHE storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days155/100IHE headlines →
Last 30 days354/100IHE headlines →
Last 90 days1555.4/100IHE headlines →

Latest stories on IHE

2d ago
Oct 12
Better Pharma ETF: iShares IHE vs. State Street XPH
The Motley Fool50 · neutralgeneral
Oct 10
Sep 15
Sep 15
IHE: Large-Cap Pharma Cools After A Hot Summer
Seeking Alpha42 · neutralgeneral
Sep 10
Sep 8
Sep 8
Sep 8
Sep 8
Aug 21
Aug 20
Aug 13
Aug 13
XLV vs. IHE: Which Healthcare ETF Is the Better Buy?
The Motley Fool55 · neutralgeneral
Jul 31
Jul 23
Jul 22
Jul 22
Jul 19
Jul 19
Jul 19
Jul 19
Jul 16
Jul 16
Jul 10
Open IHE in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →